In a four-week period spanning October and November, about 20 companies ran more than 2,100 ads on Facebook and Instagram that described benefits of prescription drugs without citing risks, promoted drugs for unapproved uses or featured testimonials without disclosing whether they came from actors or company employees, according to a Wall Street Journal analysis of ads collected by the nonprofit Algorithmic Transparency Institute from Meta Platforms Inc.’s ad library.
The Wall Street Journal | December 2022, Khadeeja SafdarFollow
and Andrea Fuller